Funded Tech Companies
Thymmune
Thymmune is a biopharmaceutical venture, based in Cambridge. Financial backing was provided by Pillar VC, NYBC Ventures and private investors.
Company Overview
Company Name
Thymmune
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
c/o LabCentral 700 Main Street North
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale. The company is developing a pipeline of therapies to treat immunodeficiencies, transplant-related, and autoimmune disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/1/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stan Wang
Chief Scientific Officer
Bing Lim
Company Investors
- Pillar VC
- NYBC Ventures
- Private Investors (George Church)
- Private Investors (James Fordyce)
- Private Investors (John Maraganore)
- Private Investors (Judy Pagliuca)
- Private Investors (Mark Bamforth)
- Private Investors (Philip Reilly)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs